ES2094622T3 - Derivados triterpenos y antagonistas del receptor de endotelina que los contiene. - Google Patents

Derivados triterpenos y antagonistas del receptor de endotelina que los contiene.

Info

Publication number
ES2094622T3
ES2094622T3 ES94304165T ES94304165T ES2094622T3 ES 2094622 T3 ES2094622 T3 ES 2094622T3 ES 94304165 T ES94304165 T ES 94304165T ES 94304165 T ES94304165 T ES 94304165T ES 2094622 T3 ES2094622 T3 ES 2094622T3
Authority
ES
Spain
Prior art keywords
derivatives
triterpen
antagonists
hydrogen
endothelin receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94304165T
Other languages
English (en)
Inventor
Toshiro Konoike
Yoshitaka Araki
Tetsuyoshi Hayashi
Kensuke Sakurai
Takehiko Tozyo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2094622T3 publication Critical patent/ES2094622T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTAN DERIVADOS DEL TRITERPENO DE LA FORMULA (I) EN DONDE R1 ES HIDROGENO O UN RESIDUO DE ESTER METABOLICO, Y R2 ES HIDROGENO O -R3-R4 EN DONDE R3 ES SO3-, -CH2COO-, -COCOO-, O -COR5COORIOR), Y R4 ES HIDROGENO O UN RESIDUO DE ESTER METABOLICO, ASI COMO LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, QUE TIENEN ACTIVIDADES ANTIENDOTELINA Y POR LO TANTO SON UTILES EN LA PROFILAXIS Y TRATAMIENTO DE ENFERMEDADES PROVOCADAS POR UNA SECRECION EXCESIVA DE ENDOTELINA.
ES94304165T 1993-06-11 1994-06-09 Derivados triterpenos y antagonistas del receptor de endotelina que los contiene. Expired - Lifetime ES2094622T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14041693 1993-06-11

Publications (1)

Publication Number Publication Date
ES2094622T3 true ES2094622T3 (es) 1997-01-16

Family

ID=15268217

Family Applications (2)

Application Number Title Priority Date Filing Date
ES95112524T Expired - Lifetime ES2116663T3 (es) 1993-06-11 1994-06-09 Compuestos intermediarios para la preparacion de derivados triterpenos antagonistas del receptor de endotelina.
ES94304165T Expired - Lifetime ES2094622T3 (es) 1993-06-11 1994-06-09 Derivados triterpenos y antagonistas del receptor de endotelina que los contiene.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES95112524T Expired - Lifetime ES2116663T3 (es) 1993-06-11 1994-06-09 Compuestos intermediarios para la preparacion de derivados triterpenos antagonistas del receptor de endotelina.

Country Status (11)

Country Link
US (2) US5463107A (es)
EP (2) EP0628569B1 (es)
JP (1) JP2724114B2 (es)
KR (1) KR100201015B1 (es)
CN (2) CN1041938C (es)
AT (2) ATE165811T1 (es)
DE (2) DE69400506T2 (es)
DK (1) DK0628569T3 (es)
ES (2) ES2116663T3 (es)
GR (1) GR3021952T3 (es)
TW (1) TW272974B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2116663T3 (es) 1993-06-11 1998-07-16 Shionogi & Co Compuestos intermediarios para la preparacion de derivados triterpenos antagonistas del receptor de endotelina.
KR100399797B1 (ko) * 1995-06-02 2004-04-13 시오노기세이야쿠가부시키가이샤 뇌부종억제제
WO1997027314A1 (fr) * 1996-01-23 1997-07-31 Shionogi & Co., Ltd. Processus de production d'analogues d'acide oleanolique par la culture de racine pileuse
TWI232102B (en) * 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
JP2007217438A (ja) * 2001-07-17 2007-08-30 Shionogi & Co Ltd 注射用医薬製剤
JP4437923B2 (ja) 2002-03-22 2010-03-24 塩野義製薬株式会社 トリテルペン誘導体の製造方法
EP1629853A1 (en) * 2003-06-04 2006-03-01 SHIONOGI & CO., LTD. Method for preparing powder exhibiting low susceptibility to electrification
TWI335335B (en) * 2004-03-24 2011-01-01 Shionogi & Co A novel crystal of a triterpene derivative
JP4827189B2 (ja) 2004-05-14 2011-11-30 塩野義製薬株式会社 過酸化水素およびタングステン触媒を用いたアルコールの酸化反応
JPWO2006077801A1 (ja) * 2005-01-18 2008-06-19 塩野義製薬株式会社 ミリセロン誘導体の製造方法
EP1964556A4 (en) * 2005-12-21 2010-03-24 Shionogi & Co THERAPEUTIC AGENT OR THERAPEUTIC PROCEDURE AGAINST ISCHEMIC STROKE
WO2007103727A2 (en) * 2006-03-03 2007-09-13 Savipu Pharmaceuticals Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of nf-kb
US7323476B2 (en) * 2006-03-03 2008-01-29 Savipu Pharmaceuticals Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseases
US20070207989A1 (en) * 2006-03-03 2007-09-06 Savipu Pharmaceuticals Diterpene derivatives for the treatment of cardiovascular, cancer and inflammatory diseases
US20070243273A1 (en) * 2006-04-12 2007-10-18 Savipu Pharmaceuticals Reduction of the Deleterious Effects of Tobacco Smoking
US20080017207A1 (en) * 2006-07-18 2008-01-24 Savipu Pharmaceuticals Reduction of the Deleterious Effects of Tobacco Smoking by the Induction of Phase 2 Enzymes by Nerf2
US20080187608A1 (en) * 2007-02-05 2008-08-07 Savipu Pharmaceuticals Enriched fractions from clary sage for the treatment of cancer, cardiovascular and inflammatory diseases
US20090022821A1 (en) * 2007-07-17 2009-01-22 Inderjit Kumar Dev Compositions from wax myrtle for the treatment of cancer, cardiovascular and inflammatory diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2115665T3 (es) 1991-01-29 1998-07-01 Shionogi & Co Derivado de triterpeno.
ES2116663T3 (es) 1993-06-11 1998-07-16 Shionogi & Co Compuestos intermediarios para la preparacion de derivados triterpenos antagonistas del receptor de endotelina.

Also Published As

Publication number Publication date
TW272974B (es) 1996-03-21
CN1106368A (zh) 1995-08-09
KR100201015B1 (ko) 1999-06-15
ES2116663T3 (es) 1998-07-16
KR950000663A (ko) 1995-01-03
ATE165811T1 (de) 1998-05-15
DE69400506D1 (de) 1996-10-17
EP0682009A3 (en) 1997-02-05
EP0682009B1 (en) 1998-05-06
EP0682009A2 (en) 1995-11-15
US5463107A (en) 1995-10-31
ATE142640T1 (de) 1996-09-15
EP0628569A1 (en) 1994-12-14
GR3021952T3 (en) 1997-03-31
EP0628569B1 (en) 1996-09-11
DE69410081T2 (de) 1998-10-08
DE69400506T2 (de) 1997-02-13
CN1215725A (zh) 1999-05-05
DK0628569T3 (da) 1996-09-30
CN1070183C (zh) 2001-08-29
CN1041938C (zh) 1999-02-03
DE69410081D1 (de) 1998-06-10
JPH0753484A (ja) 1995-02-28
JP2724114B2 (ja) 1998-03-09
US5587505A (en) 1996-12-24

Similar Documents

Publication Publication Date Title
ES2094622T3 (es) Derivados triterpenos y antagonistas del receptor de endotelina que los contiene.
ES2117249T3 (es) Derivados de 2,6-diaminopurina.
ES2117034T3 (es) Composicion para la limpieza de vidrio.
DK1920764T3 (da) Fluprostenolisopropylester til anvendelse i behandling af glaukom og okulær hypertension
ES2113127T3 (es) Derivado de androstenona.
DK0526642T3 (da) Triterpenderivat
ES2172580T3 (es) 1,3-oxatiolanos sustituidos con propiedades antiviricas.
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ES2154262T3 (es) Uso de compuestos macrolidos para enfermedades oculares.
GR3004518T3 (es)
PE13391A1 (es) Procedimiento de preparacion de derivados de piperazina
ES2121003T3 (es) Nuevos derivados del acido metilenbisfosfonico.
MD306B1 (ro) Remediu pentru profilaxia afectiunilor vasculare determinate de actiunea peroxizilor glicoproteinfixati
FI851261A0 (fi) Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
AR003107A1 (es) Derivados de vitamina d para uso dermatologico, composiciones farmaceuticas que los contienen y procedimiento para la preparacion de dichos derivados.
EP0150015A3 (en) Norbornane and norbornene carboxylic acid amides, process for their preparation and their use as medicines
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
ZA894397B (en) Analgesic phenothiazine derivatives
ES2166838T3 (es) 6-(triazolil(3-(trifluorometil)fenil)metil)-2-quinolinonas y -quinolinationas.
AR007369A1 (es) El uso de derivados carboxilados y un medicamento que contiene uno o mas de dichos derivados
DK0532177T3 (da) Methanoanthracener som dopaminantagonister
SE8802814D0 (sv) Beredningar for lokal anvendning
SE8008189L (sv) Foreningar med antiallergisk och antiulceros verkan, nemligen 1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxamider och mellanprodukter for dessa
ES472208A1 (es) Procedimiento para la obtencion de nuevos derivados de 2- bencimidazol.
ATE92461T1 (de) Gegen die zerebrale insuffizienz wirksame verbindungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 628569

Country of ref document: ES